Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF Read more about Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF
Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis Read more about Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis
Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis Read more about Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis
Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome Read more about Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome
An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus Read more about An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus
Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005) Read more about Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005)
Evaluation of Feeding Intolerance in Premature Infants Using Near Infrared Spectroscopy Read more about Evaluation of Feeding Intolerance in Premature Infants Using Near Infrared Spectroscopy
Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy Read more about Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis Read more about A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis